Folgen
Keine Story von Gerresheimer AG mehr verpassen.
Filtern
  • 18.02.2021 – 07:00

    Gerresheimer presents strong fourth quarter

    Duesseldorf (ots) - – Transformation in full swing: Continuous focus on growth delivers first positive results – Fourth-quarter Group revenues rise to 403m Euro: 7.3 % organic growth in the core business – Fourth-quarter adjusted EBITDA up to 100m Euro; 6.5 % organic growth in the core business – Target range for the financial year 2020 reached ...

    Ein Dokument
  • 08.12.2020 – 15:15

    Gerresheimer: On the path to sustainable profitable growth

    Duesseldorf (ots) - - Transformation into a growth value as innovation leader and solution provider - Gerresheimer presents strategy process formula G as an engine towards sustainable profitable growth - Over proportional growth will be achieved by expanding in high value solutions, digital applications and growth regions - Strategic investments in growth ...

    Ein Dokument
  • 13.10.2020 – 07:01

    Gerresheimer on track for strong second half-year

    Dusseldorf (ots) - · Third quarter on schedule · Group revenues EUR 349m; 2.1% organic revenue growth in core business · Adjusted EBITDA increases by 4.1% to EUR 75m · Significant improvement in free cash flow to EUR 38m · Strong fourth quarter 2020 expected · Guidance for 2020 confirmed Gerresheimer AG delivered profitable growth in its core business ...

    Ein Dokument
  • 14.07.2020 – 07:00

    Gerresheimer with strong second quarter

    Duesseldorf (ots) - - Implementation of growth strategy beginning to deliver results - Group revenues increase to EUR 363m with 4.6% organic growth in core business - 6.9% organic growth in adjusted EBITDA to EUR 84m - Impacts of pandemic under control; potential vaccination campaigns open opportunities for specialty glass vials - Revenue guidance for 2020 ...

    Ein Dokument
  • 16.06.2020 – 14:00

    Leading pharma packaging companies commit to supply for Covid-19 fight

    Düsseldorf (ots) - Stevanato Group, SCHOTT, and Gerresheimer confirm the readiness to support future Covid-19 Vaccine with pharmaceutical containers The CEOs of Gerresheimer, Stevanato Group, and SCHOTT are committed to ensuring ample supply of pharmaceutical containers for any Covid-19 vaccine and ...

    Ein Dokument
  • 09.04.2020 – 07:00

    Gerresheimer business model robust

    Duesseldorf (ots) - - Stable business model as key supplier to pharma and healthcare industry - Gerresheimer sustains growth path. Revenue guidance for 2020 in the mid single-digit percentage range and adjusted EBITDA margin of around 21% confirmed - Refinancing of EUR 190m promissory loan maturing in November 2020 secured ahead of time - First quarter level with prior year, as expected: revenues EUR 304m, ...

    Ein Dokument
  • 19.02.2020 – 07:30

    Gerresheimer sets foundation for profitable growth in 2019

    Duesseldorf (ots) - -Foundation for sustainable and profitable growth laid in 2019: Annual revenue growth in the mid-single-digit percentage range targeted for 2020 and subsequent years -2019 operating targets met: Underlying revenues reach EUR 1.40bn and underlying adjusted EBITDA EUR 293m -Further increase in proposed dividend to EUR 1.20 per share from ...

    Ein Dokument
  • 10.10.2019 – 08:33

    Gerresheimer advances growth and technology projects in third quarter

    Düsseldorf (ots) - - Revenues up 1.4 % on the prior-year quarter to EUR 358.6m - Adjusted EBITDA at EUR 72.2m in third quarter of 2019 - Adjusted net income at EUR 30.7m in third quarter of 2019 - New innovation center for pharmaceutical glass opened in the US - Successful refinancing by a EUR 550.0m ...

    Ein Dokument
  • 07.10.2019 – 12:15

    Gerresheimer opens Glass Innovation and Technology Center in the U.S.

    Düsseldorf/Vineland, New Jersey (ots) - Gerresheimer is driving innovation in pharmaceutical glass, primary packaging glass products, technologies and digitized processes. In the future, highly qualified engineers at the recently opened "Gx Glass Innovation and Technology Center" will develop innovative ...

    Ein Dokument
  • 11.07.2019 – 07:30

    Gerresheimer reports strong second quarter

    Duesseldorf (ots) - - Revenues up 7.2% on the prior-year quarter to EUR 356.5m - Adjusted EBITDA at EUR 74.2m in second quarter of 2019 (Q2 2018: EUR 71.1m), excluding EUR 26.2m from derecognition of contingent purchase price components in connection with Sensile Medical acquisition - Revenue guidance confirmed without change; guidance on adjusted EBITDA at ...

    Ein Dokument
  • 14.05.2019 – 10:00

    Dr. Bernd Metzner to become Chief Financial Officer of Gerresheimer AG on May 15, 2019

    Düsseldorf (ots) - Dr. Bernd Metzner (48) takes up the position of Chief Financial Officer of Gerresheimer AG on May 15, 2019. Dr. Metzner had been Chief Financial Officer of SDAX-listed Ströer SE & Co. KGaA since 2014. "I very much welcome the financial expertise and years of industry experience that ...

    Ein Dokument
  • 11.04.2019 – 07:30

    Gerresheimer makes good start into the new financial year

    Duesseldorf (ots) - - Revenues up 6.3% on the prior-year quarter to EUR 308.5m - Adjusted EBITDA at EUR 145.9m in first quarter of 2019 (Q1 2018: EUR 52.6m), comprising of EUR 53.6m plus EUR 92.3m from partial derecognition of contingent purchase price components connected to the Sensile Medical acquisition - Guidance for adjusted EBITDA at constant ...

    Ein Dokument
  • 14.02.2019 – 07:30

    Gerresheimer back on growth path and sets course for the future

    Duesseldorf (ots) - - Revenues at constant exchange rates up 4.3% in the financial year 2018 to EUR 1,406.7m - Adjusted EBITDA at constant exchange rates at EUR 307.5m, excluding the Advanced Technologies Division and other one-off effects, and despite substantially negative energy costs and resin prices - Strong adjusted net income after non-controlling ...

    Ein Dokument
  • 28.11.2018 – 10:00

    Dr. Bernd Metzner to become Chief Financial Officer of Gerresheimer AG

    Düsseldorf (ots) - Dr. Bernd Metzner (48) is to become Chief Financial Officer of Gerresheimer AG, taking up office at the latest on July 1, 2019. Dr. Bernd Metzner has been Chief Financial Officer of SDAX-listed Ströer SE & Co. KGaA since 2014. "In Dr. Bernd Metzner, we have gained a highly ...

    Ein Dokument
  • 11.10.2018 – 07:56

    Gerresheimer increases revenues by 8.8% and successfully integrates Sensile Medical

    Düsseldorf (ots) - - Revenues at constant exchange rates up 8.8% in third quarter of 2018 to EUR 364.4m - Adjusted EBITDA at constant exchange rates - excluding Sensile Medical and negative effects relating to the exemption from electricity network charges - increased by EUR 1.3m in third quarter to EUR ...

    Ein Dokument
  • 11.10.2018 – 07:46

    Andreas Schütte steps down from Management Board of Gerresheimer AG

    Düsseldorf (ots) - Andreas Schütte (56) will step down from the Management Board of Gerresheimer AG at his own request as of February 28, 2019 in order to pursue new career challenges. The Supervisory Board of Gerresheimer AG approved this wish at its meeting yesterday. Andreas Schütte has served on ...

    Ein Dokument
  • 06.09.2018 – 12:04

    Dietmar Siemssen appointed new CEO of Gerresheimer AG

    Duesseldorf (ots) - - Dietmar Siemssen to assume as Chief Executive Officer on November 1, 2018 - Previously held position as Stabilus CEO - Speaker of the Management Board and CFO Rainer Beaujean will not extend contract after April 30, 2019 Dietmar Siemssen (55) will join the Management Board of Gerresheimer AG as Chief Executive Officer on November 1, ...

    Ein Dokument
  • 11.07.2018 – 21:37

    Gerresheimer extends business model and increases growth forecast

    Düsseldorf (ots) - - With the acquisition of Sensile Medical, Gerresheimer is extending its business model in the direction of an Original Equipment Manufacturer (OEM) for drug delivery platforms with digital and electronic capabilities for pharmaceutical and biopharmaceutical customers. The purchase ...

    Ein Dokument